Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)

Sponsor
Harvard School of Public Health (HSPH) (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03328546
Collaborator
National Institutes of Health (NIH) (NIH), National Cancer Institute (NCI) (NIH), National Institute of Environmental Health Sciences (NIEHS) (NIH)
116,671
479

Study Details

Study Description

Brief Summary

To study, prospectively, the association between dietary patterns and risk of health outcomes (cardiovascular, metabolic, endocrine, neurological, skeletal muscular, cancer) in cohort study of 116,671 women age 24 to 44 years at baseline in 1989 (the Nurses' Health Study II; NHS II).

Detailed Description

Health status and lifestyle information was self-reported on a questionnaire at baseline, and on questionnaires distributed to participants biennially thereafter. Dietary intake data was collected in form of a comprehensive, 131-item food frequency questionnaire (FFQ), distributed among participants every four years. The response rate remained over 90%. Dietary data was validated using biomarkers, health status data using medical records.

Dietary pattern scores were derived from FFQs using cumulative average whenever possible from years preceding the outcomes.

Multivariable Cox proportional hazards models were used to evaluate associations between dietary pattern scores and health outcomes, except in case of pregnancy complications (such as gestational diabetes mellitus/GDM and hypertensive disorders of pregnancy/HDPs) where multivariable logistic regression models with generalized estimating equations, with an exchangeable working correlation structure to account for correlated outcomes between pregnancies.

Study Design

Study Type:
Observational
Actual Enrollment :
116671 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)
Actual Study Start Date :
Jan 1, 1989
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2028

Outcome Measures

Primary Outcome Measures

  1. Myocardial infarction [1989-2017]

    Necrosis of heart muscle secondary to prolonged ischemia.

  2. Coronary heart disease [1989-2017]

    Atherosclerosis

  3. Stroke [1989-2017]

    Sudden death of brain cells due to lack of oxygen

  4. Diabetes Mellitus (type 2) [1989-2017]

    Insulin resistance

  5. Gestational Diabetes Mellitus [1989-2017]

    Glucose intolerance with onset/first recognition during pregnancy

  6. Hypertensive disorders [1989-2017]

    Chronic hypertension

  7. Hypertensive disorders of pregnancy [1989-2001]

    Pregnancy induced hypertension, toxemia/preeclampsia

  8. Colon cancer [1989-2017]

    Malignant tumor in the colon

  9. Breast cancer [1989-2017]

    Malignant tumor of breast cells

  10. Fractures [1989-2017]

    Fragility fractures of common sites such as hip and wrist.

  11. Physical functioning [1989-2017]

    Physical function such as falls, walking, and self care

Eligibility Criteria

Criteria

Ages Eligible for Study:
24 Years to 44 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All women without history of chronic disease and/or primary outcome at the time of recruitment. Women contribute person-time until a first diagnosis of the primary outcome or until the end of follow-up.

  • All women who reported a singleton pregnancy between 1991-2001 (data on pregnancy outcomes was collected on biennial questionnaires until 2001, since majority of women exited the reproductive age by then) (only for maternal outcomes)

Exclusion Criteria:
  • women with a history of chronic disease (type 2 diabetes, cardiovascular disease, or cancer) or other disease studied as the primary outcome

  • women with a missing or incomplete FFQ (more than 70 out of 131 items missing, or with caloric intake <800 kcal/day or >3500kcal/day) prior to endpoint.

  • women with missing data on the primary outcome on biennial questionnaire.

  • twin/multiple pregnancy (only for maternal outcomes)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Harvard School of Public Health (HSPH)
  • National Institutes of Health (NIH)
  • National Cancer Institute (NCI)
  • National Institute of Environmental Health Sciences (NIEHS)

Investigators

  • Principal Investigator: Walter C. Willett, MD, DrPH, Harvard School of Public Health (HSPH)

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Walter C. Willett, NHS II Principal Investigator; Professor of Epidemiology and Nutrition, Harvard School of Public Health (HSPH)
ClinicalTrials.gov Identifier:
NCT03328546
Other Study ID Numbers:
  • NHS2/DPS-GEN
  • UM1CA176726
  • K99ES026648
  • K01DK103720-01
First Posted:
Nov 1, 2017
Last Update Posted:
Mar 2, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2022